CIBC Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
CIBC Asset Management's ABMD Position: Q4 2022 in Review
CIBC Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,040 shares — an estimated $1.48M sold.
CIBC Asset Management first reported a position in ABMD in Q3 2017 and held it in 21 quarters. The position peaked at $1.73M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- CIBC Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- CIBC Asset Management sold 6,040 Abiomed Inc shares in Q4 2022, an estimated $1.48M.
- CIBC Asset Management first reported a position in Abiomed Inc in Q3 2017 and held it in 21 quarters.
- CIBC Asset Management's Abiomed Inc position peaked at $1.73M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on CIBC Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.